Skip to main content
Premium Trial:

Request an Annual Quote

Brooks Automation Acquires 4titude for $65M

NEW YORK (GenomeWeb) – Brooks Automation announced Thursday afternoon that it has acquired UK-based scientific tools and consumables maker 4titude for $65 million in cash.

Brooks also said it has signed a seven-year, $200 million senior term loan agreement with a group of institutional investors, including Morgan Stanley Senior Funding, which is acting as administrative agent.

4titude sells a variety of life science consumables and instruments, including PCR and sequencing tubes, plates, and seals; assay plates; heat sealing instrumentation and materials; and liquid handling robotics. According to Brooks, the company has had 20 percent annual growth in the last two years, and generated roughly $14 million in revenues over the past 12 months.

"As our services have expanded into supporting the genomic analysis process for many of our storage customers, [with 4titude] we now have a premier consumables offering that gives our customers the sample quality and integrity they require in this high-growth application space," Brooks President Dusty Tenney said in a statement.

Additional terms of the acquisition were not disclosed.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.